Home > Insider Trading > Filing (0001140361-17-040543)

Filing Details

Accession Number:: 0001140361-17-040543
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-11-01 17:03:30
Reporting Period:: 2017-10-30

Accepted Time:: 2017-11-01 17:03:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581720	Loxo Oncology Inc.	LOXO	Pharmaceutical Preparations (2834)	462996673

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612312	H. Joshua Bilenker	C/O Loxo Oncology, Inc. 281 Tresser Boulevard, 9Th Floor Stamford CT 06901	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-10-30	7,500	$1.18	196,207	No	4	M	Direct
Common Stock	Disposition	2017-10-30	5,690	$86.88	190,517	No	4	S	Direct
Common Stock	Disposition	2017-10-30	998	$87.74	189,519	No	4	S	Direct
Common Stock	Disposition	2017-10-30	812	$88.77	188,707	No	4	S	Direct
Common Stock	Acquisiton	2017-10-31	7,500	$1.18	196,207	No	4	M	Direct
Common Stock	Disposition	2017-10-31	2,961	$86.18	193,246	No	4	S	Direct
Common Stock	Disposition	2017-10-31	4,339	$86.65	188,907	No	4	S	Direct
Common Stock	Disposition	2017-10-31	200	$87.67	188,707	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2017-10-30	7,500	$0.00	7,500	$1.18
Common Stock	Employee Stock Option (right to buy)	Disposition	2017-10-31	7,500	$0.00	7,500	$1.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
127,190		2023-11-14	No	4	M	Direct
119,690		2023-11-14	No	4	M	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $86.26 to $87.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $87.28 to $88.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $88.34 to $89.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $85.46 to $86.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $86.46 to $87.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $87.59 to $87.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The stock option is immediately exercisable in full, and vests as to 25% of the shares subject to the option on the one-year anniversary of the vesting commencement date, and thereafter as to 1/48th of the shares in equal monthly installments.